Revolutionizing Cancer Care: Dignitana Partners with InfuSystem for Enhanced Customer Support

Scalp cooling innovator Dignitana AB has announced the expansion of its partnership with InfuSystem Holdings, Inc. to enhance field service support for The DigniCap Scalp Cooling System in U.S. chemotherapy infusion centers.

As part of the Field Service Agreement, certified InfuSystem Field Specialists will provide biomedical services including:

• Telephone support
• Repair solutions
• Annual preventive maintenance

These services will be conducted both on-site and off-site at one of InfuSystem’s seven service centers. Currently, around 300 infusion centers offer DigniCap scalp cooling to patients undergoing chemotherapy.

Fredrik Jonsson, Dignitana's CEO, emphasized that this agreement is crucial for the company's growth strategy in the U.S. market, stating, "Healthcare customers need fast and reliable service, and Dignitana has a solid reputation for exemplary support. As we are growing, we need to ensure that our customers continue to receive that high level of personal attention, no matter where they are located. InfuSystem’s extensive service fleet ensures minimal downtime so that as many patients as possible can use DigniCap during treatment."

InfuSystem is recognized as a leading national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and healthcare providers. They deliver ambulatory pumps and supplies, along with related clinical, biomedical, and billing services, improving clinician access to quality medical equipment and promoting patient wellness and safety while reducing the overall cost of infusion care. InfuSystem operates Centers of Excellence across various states in the U.S. and in Ontario, Canada.

For More Information Contact:
Fredrik Jonsson, CEO, fredrik.jonsson@dignitana.com +46 708766444

About Dignitana:
Dignitana AB is the world leader in clinically superior scalp cooling technology, producing The DigniCap® Scalp Cooling System, a patented medical cooling device that minimizes hair loss during chemotherapy. FDA cleared since 2015, DigniCap offers continuous cooling with high efficacy, safety, and patient comfort. The system was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden, with headquarters in Lund, Sweden, and U.S. operations based in Dallas, Texas. Learn more at www.dignitana.com or www.dignicap.com.